Immunity to Melanoma Antigens: From Self‐Tolerance to Immunotherapy-Reference-Cited by-同舟云学术

Immunity to Melanoma Antigens: From Self‐Tolerance to Immunotherapy

Published:2006 Issue: Volume: Page:243-295
ISSN:0065-2776
Container-title:Advances in Immunology
language:
Short-container-title:

Author:

Slingluff Craig L.,Chianese‐Bullock Kimberly A.,Bullock Timothy N.J.,Grosh William W.,Mullins David W.,Nichols Lisa,Olson Walter,Petroni Gina,Smolkin Mark,Engelhard Victor H.

Publisher

Elsevier

Reference162 articles.

1. Selective expansion of high‐ or low‐avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy;Alexander‐Miller;Proc. Natl. Acad. Sci. USA,1996

2. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL;Alexander‐Miller;J. Exp. Med.,1996

3. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells;Allan;Science,2003

4. Deamidation and Amino Terminal Processing of a T cell Epitope from Tyrosinase Requires ER to Cytosol Translocation, Peptide‐N‐glycanase, and ERAP1;Altrich‐VanLith,2006

5. CD8+ T cell immunity against a tumor/self‐antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells;Antony;J. Immunol.,2005

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines;Cancer Research Communications;2021-11

2. Tumor Antigen-Based Nanovaccines for Cancer Immunotherapy: A Review;Journal of Biomedical Nanotechnology;2021-11-01

3. Targeting neoantigens for cancer immunotherapy;Biomarker Research;2021-07-28

4. Vaccine Strategy in Melanoma;Surgical Oncology Clinics of North America;2019-07

5. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma;International Journal of Molecular Medicine;2018-04-04